Motor Neurone Disease Epidemiology

Motor neurone disease affects about 2 in every 100,000 people each year in the UK and about 5,000 people are living with the disease at any given time.

In the United States, about 5,600 individuals are diagnosed every year The condition is slightly more common among men than women.

Age

People who develop motor neurone disease usually start to experience symptoms in their early 60s, although people in their 90s or still in their teenage years can also develop the condition.

Genetics

The majority of cases of motor neurone disease are sporadic and there is no family history of the condition. However, in about 5% of cases, a close family relative also has the condition or a similar disease called frontotemporal dementia. In familial cases, a number of defective genes that are thought to contribute to the disease have been identified.

Environmental factors

Several environmental factors have also been implicated in causing motor neurone disease but none have yet been proved to be associated with the condition. One example is American football, as three individuals who play the game have developed the condition. In addition, 50 association footballers in Italy have motor neurone disease.

Regional prevalence

For the majority of countries, the prevalence of motor neurone disease is similar. Among some areas of the world, however, an increased prevalence of the condition has been known, although this appears to be tailing off in recent decades.

One area of increased incidence is the Kii peninsula of Japan where the cycad seed is used as a medicine. The ingestion or topical application of this seed has been linked to the development of motor neurone disease. Chamorro inhabitants from the island of Guam in the Pacific Ocean also develop a special form of motor neurone disease called Guamanian ALS-PD-dementia complex or lytico bodig. It has been suggested that this condition develops in these regions due to the use of cycad nut flour in the diet or the inclusion of bats in the diet that have eaten cycad nuts.

Further Reading

Last Updated: Jul 7, 2023

Dr. Ananya Mandal

Written by

Dr. Ananya Mandal

Dr. Ananya Mandal is a doctor by profession, lecturer by vocation and a medical writer by passion. She specialized in Clinical Pharmacology after her bachelor's (MBBS). For her, health communication is not just writing complicated reviews for professionals but making medical knowledge understandable and available to the general public as well.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Mandal, Ananya. (2023, July 07). Motor Neurone Disease Epidemiology. News-Medical. Retrieved on October 31, 2024 from https://www.news-medical.net/health/Motor-Neurone-Disease-Epidemiology.aspx.

  • MLA

    Mandal, Ananya. "Motor Neurone Disease Epidemiology". News-Medical. 31 October 2024. <https://www.news-medical.net/health/Motor-Neurone-Disease-Epidemiology.aspx>.

  • Chicago

    Mandal, Ananya. "Motor Neurone Disease Epidemiology". News-Medical. https://www.news-medical.net/health/Motor-Neurone-Disease-Epidemiology.aspx. (accessed October 31, 2024).

  • Harvard

    Mandal, Ananya. 2023. Motor Neurone Disease Epidemiology. News-Medical, viewed 31 October 2024, https://www.news-medical.net/health/Motor-Neurone-Disease-Epidemiology.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.